(Q72143102)
Statements
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group (English)
M Di Bartolomeo
E Bajetta
A M Bochicchio
C Carnaghi
L Somma
V Mazzaferro
M Visini
V Gebbia
S Tumolo